Pfizer to Acquire Coley Pharmaceutical Group
Acquisition Will Expand Pfizer's Investment in Vaccines
22-Nov-2007 -
Pfizer Inc announced it has entered into an agreement to acquire Coley Pharmaceutical Group, Inc., a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and ...
allergies
asthma
autoimmune diseases
+2